title: Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?
authors.forename: Paolo
authors.initials: P
authors.lastname: Vescovi
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Merigo
authors.forename: Marco
authors.initials: M
authors.lastname: Meleti
authors.forename: Maddalena
authors.initials: M
authors.lastname: Manfredi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001861:Bone Regeneration / Q000528:radiation effects; D002113:Calcification, Physiologic / Q000528:radiation effects; D003131:Combined Modality Therapy; D003646:Debridement; D004164:Diphosphonates / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000532:radiotherapy*; D028022:Low-Level Light Therapy / Q000379:methods*; D010020:Osteonecrosis / Q000139:chemically induced / Q000532:radiotherapy*; D016896:Treatment Outcome; D014945:Wound Healing / Q000528:radiation effects
chemical_list: D000900:Anti-Bacterial Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates